Drug Markets/Alcaftadine

Alcaftadine

1 NDC across 1 manufacturer|0 Generic,1 Brand

Alcaftadine is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jul 28, 2010, and the first generic was approved Jun 23, 2023.

Alcaftadine is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $2.83 to $2.83 per ML. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$2.83 – $2.83

per ML

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing ALCAFTADINE

Drug Portfolio

1 NDCs total, 1 shown

Drug Price 7d Change
LASTACAFT ONCE DAILY 0.25% DRP
$2.8333
per ML

Frequently Asked Questions

What is Alcaftadine used to treat?

Alcaftadine is used to treat allergic conjunctivitis, per the National Library of Medicine's MED-RT classification.

When did Alcaftadine become available as a generic?

FDA approved the first generic Alcaftadine (ANDA) on Jun 23, 2023.

How many Alcaftadine products are on the market?

The Alcaftadine drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Alcaftadine?

NADAC reference prices for Alcaftadine range from $2.8333 to $2.8333 per ML.

Which manufacturers make Alcaftadine?

1 manufacturer lists Alcaftadine in NADAC. Ranked by number of NDCs, the largest are Allergan, Inc. (1).